YECO OTC
EV Biologics, Inc.
1W: +0.0%
1M: -75.0%
3M: -50.0%
YTD: -99.9%
1Y: -99.9%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$178K
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$299K
+0.0% ▲
Net Income
-$299K
+0.0% ▲
EPS (Diluted)
$-0.03
+0.0% ▲
EBITDA
-$299K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $119K | $0 | $49K | $178K |
| YoY Growth | +0.0% | +0.0% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $119K | $0 | $49K | $0 |
| Gross Margin | — | 100.0% | — | 100.0% | 0.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $99K | $143K | $590K | $532K | $477K |
| Operating Expenses | $99K | $143K | $590K | $532K | $477K |
| Operating Income | -$99K | -$24K | -$590K | -$483K | -$299K |
| Operating Margin | — | -20.4% | — | -987.9% | -167.4% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$99K | -$388K | -$21M | -$1M | -$299K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$99K | -$388K | -$21M | -$1M | -$299K |
| Net Margin | — | -326.1% | — | -2591.3% | -167.4% |
| EPS (Diluted) | $-0.01 | $-0.05 | $-2.91 | $-0.12 | $-0.03 |
| EBITDA | -$99K | -$151K | -$21M | -$1M | -$299K |
| Shares Outstanding | 7M | 7M | 7M | 10M | 10M |